WASHINGTON (AP) — Telehealth company Hims & Hers said Thursday it will launch a cheaper, off-brand version of the weight-loss pill Wegovy, just weeks after drugmaker Novo Nordisk launched its highly ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. E. coli linked to cheddar cheese made ...

Discover the groundbreaking capsule endoscopy—a tiny, wireless camera encased in a transparent pill-sized capsule. This advanced medical device offers a non-invasive way to examine the small intestine ...

Abstract: Early detection of small intestinal cancer is crucial due to subtle symptoms. This research addresses camera-based Wireless Capsule Endoscopy (WCE) limitations in visualizing specific ...

A new Brazilian magnetic tracking technology aims to provide real-time, radiation-free evaluation of gastrointestinal transit in outpatient settings, potentially expanding access to functional testing ...

COPENHAGEN, Denmark – Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering doses of 1.5 milligrams and 4 mg at $149 per month for self-paying ...

NEW YORK - Packaged food makers and fast-food restaurants may be forced to overhaul more of their products next year as newly approved, appetite-suppressing GLP-1 pills become available in January, ...

Merck (MRK) announced on Wednesday that its single-tablet antiviral regimen, doravirine and islatravir for adults with HIV, was found to be non-inferior to Gilead’s (GILD) once-daily HIV pill Biktarvy ...

Gilead Sciences Inc. (NASDAQ: GILD) on Thursday shared topline results from the Phase 3 ARTISTRY-1 trial. The open-label trial evaluated the treatment responses of HIV patients who are virologically ...